Finch Therapeutics Group Inc is a microbiome technology company with a portfolio of intellectual property and microbiome assets.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Mark Smith, PhD$2.9M
Market Cap • 27/05/20242017
(há 7 anos)
NASDAQ
Listagem
Boston
Sede • Massachusetts18
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
FNCHSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.